The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells
Leder, A., & Leder, P. (1975) · Cell · doi:10.1016/0092-8674(75)90107-5 · Cited by 650
Two Types of Ribosome in Mouse–Hamster Hybrid Cells
STANNERS, C. P., ELICEIRI, G. L., & GREEN, H. (1971) · Nature New Biology · doi:10.1038/newbio230052a0 · Cited by 560
Ruiz-Carrillo, A., Wangh, L. J., & Allfrey, V. G. (1975) · Science · doi:10.1126/science.1166303 · Cited by 441
Commitment to erythroid differentiation by friend erythroleukemia cells: a stochastic analysis
Gusella, J., Geller, R., Clarke, B., Weeks, V., & Housman, D. (1976) · Cell · doi:10.1016/0092-8674(76)90113-6 · Cited by 356
Histones of Drosophila Embryos
Alfageme, C. R., Zweidler, A., Mahowald, A., & Cohen, L. H. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42534-9 · Cited by 336
Effect of sodium butyrate on mammalian cells in culture: A review
Prasad, K. N., & Sinha, P. K. (1976) · In Vitro · doi:10.1007/bf02796360 · Cited by 327
Chemical Studies of Histone Acetylation
Gershey, E. L., Vidali, G., & Allfrey, V. G. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91985-x · Cited by 306
Growth Inhibition and Morphological Changes Caused by Lipophilic Acids in Mammalian Cells
Ginsburg, E., Salomon, D., Sreevalsan, T., & Freese, E. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.8.2457 · Cited by 176
Morphology and growth rate changes in Chinese hamster cells cultured in presence of sodium butyrate
Wright, J. R. (1973) · Experimental Cell Research · doi:10.1016/0014-4827(73)90091-8 · Cited by 149
Griffin, M. J., Price, G. H., Bazzell, K. L., et al. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(74)90073-3 · Cited by 116
Cited by
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Seto, E., & Yoshida, M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018713 · Cited by 1,989
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
Inhibition of Histone Deacetylase Activity by Butyrate
Davie, J. R. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.7.2485s · Cited by 1,515
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Gut microbial metabolites as multi-kingdom intermediates
Krautkramer, K. A., Fan, J., & Bäckhed, F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0438-4 · Cited by 1,398
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Sodium butyrate inhibits histone deacetylation in cultured cells
Candido, E. (1978) · Cell · doi:10.1016/0092-8674(78)90305-7 · Cited by 1,036
Microbial Regulation of Host Physiology by Short-chain Fatty Acids
van der Hee, B., & Wells, J. M. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.02.001 · Cited by 980
Yang, X.-J., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210599 · Cited by 940
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis
Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.011 · Cited by 891
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
Verdin, E., & Ott, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3931 · Cited by 877
Histone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
Moreno-Yruela, C., Zhang, D., Wei, W., Bæk, M., Liu, W., Gao, J., Danková, D., Nielsen, A. L., Bolding, J. E., Yang, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi6696 · Cited by 841
Effects of sodium butyrate, a new pharmacological agent, on cells in culture
Kruh, J. (1981) · Molecular and Cellular Biochemistry · doi:10.1007/bf00222695 · Cited by 802
Iddir, M., Brito, A., Dingeo, G., Fernandez Del Campo, S. S., Samouda, H., La Frano, M. R., & Bohn, T. (2020) · Nutrients · doi:10.3390/nu12061562 · Cited by 786
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Yoshida, M., Horinouchi, S., & Beppu, T. (1995) · BioEssays · doi:10.1002/bies.950170510 · Cited by 713
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
O'Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 713
Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., & Nakanishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4592 · Cited by 694
The effect of sodium butyrate on histone modification
Sealy, L. (1978) · Cell · doi:10.1016/0092-8674(78)90306-9 · Cited by 686
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678
Acetylation of non-histone proteins modulates cellular signalling at multiple levels
Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.027 · Cited by 664
Stem cell fate in cancer growth, progression and therapy resistance
Lytle, N. K., Barber, A. G., & Reya, T. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0056-x · Cited by 647
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<1::aid-jcp1>3.0.co;2-7 · Cited by 621
Zhou, L., Zhang, M., Wang, Y., Dorfman, R. G., Liu, H., Yu, T., Chen, X., Tang, D., Xu, L., Yin, Y., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy182 · Cited by 525
Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase
Darkin-Rattray, S. J., Gurnett, A. M., Myers, R. W., Dulski, P. M., Crumley, T. M., Allocco, J. J., Cannova, C., Meinke, P. T., Colletti, S. L., Bednarek, M. A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13143 · Cited by 575
Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model
Kasahara, K., Krautkramer, K. A., Org, E., Romano, K. A., Kerby, R. L., Vivas, E. I., Mehrabian, M., Denu, J. M., Bäckhed, F., Lusis, A. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0272-x · Cited by 538
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
Archer, S. Y., Meng, S., Shei, A., & Hodin, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6791 · Cited by 535
Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S., & Beppu, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41547-5 · Cited by 514
Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4.
Sobel, R. E., Cook, R. G., Perry, C. A., Annunziato, A. T., & Allis, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1237 · Cited by 510
L'Hernault, S. W., & Rosenbaum, J. L. (1985) · Biochemistry · doi:10.1021/bi00323a034 · Cited by 497
Suppression of histone deacetylation in vivo and in vitro by sodium butyrate.
Boffa, L. C., Vidali, G., Mann, R. S., & Allfrey, V. G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34804-4 · Cited by 478
Vidali, G., Boffa, L. C., Bradbury, E. M., & Allfrey, V. G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2239 · Cited by 461
Butyrate and other short-chain fatty acids as modulators of immunity: What relevance for health?
Meijer, K., de Vos, P., & Priebe, M. G. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833eebe5 · Cited by 443
Milazzo, G., Mercatelli, D., Di Muzio, G., Triboli, L., De Rosa, P., Perini, G., & Giorgi, F. M. (2020) · Genes · doi:10.3390/genes11050556 · Cited by 423
Guerriero, C. J., & Brodsky, J. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00027.2011 · Cited by 418
The gut-bone axis: How bacterial metabolites bridge the distance
Zaiss, M. M., Jones, R. M., Schett, G., & Pacifici, R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128521 · Cited by 403
Monographs on fragrance raw materials
Opdyke, D. L. J. (1981) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(81)90363-1 · Cited by 383
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs
Hassig, C. A., & Schreiber, S. L. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80066-x · Cited by 364
Epigenetics and Bacterial Infections
Bierne, H., Hamon, M., & Cossart, P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010272 · Cited by 361
Transcriptionally active chromatin
Reeves, R. (1984) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(84)90044-7 · Cited by 355
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Li, G., Tian, Y., & Zhu, W.-G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576946 · Cited by 352
Different accessibilities in chromatin to histone acetylase.
Cousens, L. S., Gallwitz, D., & Alberts, B. M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37831-6 · Cited by 340
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Wagner, J. M., Hackanson, B., Lübbert, M., & Jung, M. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0012-4 · Cited by 338
Metabolic Regulation of Histone Post-Translational Modifications
Fan, J., Krautkramer, K. A., Feldman, J. L., & Denu, J. M. (2015) · ACS Chemical Biology · doi:10.1021/cb500846u · Cited by 330
Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle
Owa, T., Yoshino, H., Okauchi, T., Yoshimatsu, K., Ozawa, Y., Sugi, N. H., Nagasu, T., Koyanagi, N., & Kitoh, K. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9902638 · Cited by 322
Regulation of Ketone Body Metabolism and the Role of PPARα
Grabacka, M., Pierzchalska, M., Dean, M., & Reiss, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122093 · Cited by 305
Nonhistone protein acetylation as cancer therapy targets
Singh, B. N., Zhang, G., Hwa, Y. L., Li, J., Dowdy, S. C., & Jiang, S.-W. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.62 · Cited by 300
The Potential of HDAC Inhibitors as Cognitive Enhancers
Gräff, J., & Tsai, L.-H. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140216 · Cited by 298
Perrine, S. P., Hermine, O., Small, T., Suarez, F., O'Reilly, R., Boulad, F., Fingeroth, J., Askin, M., Levy, A., Mentzer, S. J., et al. (2007) · Blood · doi:10.1182/blood-2006-01-024703 · Cited by 297
Structure of chromatin containing extensively acetylated H3 and H4
Simpson, R. T. (1978) · Cell · doi:10.1016/0092-8674(78)90219-2 · Cited by 285
Siavoshian, S., Segain, J.-P., Kornprobst, M., Bonnet, C., Cherbut, C., Galmiche, J.-P., & Blottière, H. M. (2000) · Gut · doi:10.1136/gut.46.4.507 · Cited by 277
Participation of core histone "tails" in the stabilization of the chromatin solenoid.
Allan, J., Harborne, N., Rau, D. C., & Gould, H. (1982) · The Journal of cell biology · doi:10.1083/jcb.93.2.285 · Cited by 276
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
Chen, W. Y., Bailey, E. C., McCune, S. L., Dong, J.-Y., & Townes, T. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5798 · Cited by 256
Modulation of bone remodeling by the gut microbiota: A new therapy for osteoporosis
Lyu, Z., Hu, Y., Guo, Y., & Liu, D. (2023) · Bone Research · doi:10.1038/s41413-023-00264-x · Cited by 207
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
Histone Deacetylase Inhibitors Up-Regulate the Expression of Tight Junction Proteins
Bordin, M., D'Atri, F., Guillemot, L., & Citi, S. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.692.2.12 · Cited by 168
Inhibition of p300 Histone Acetyltransferase by Viral Interferon Regulatory Factor
Li, M., Damania, B., Alvarez, X., Ogryzko, V., Ozato, K., & Jung, J. U. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8254-8263.2000 · Cited by 142
Cleophas, M. C. P., Crişan, T. O., Lemmers, H., Toenhake-Dijkstra, H., Fossati, G., Jansen, T. L., Dinarello, C. A., Netea, M. G., & Joosten, L. A. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206258 · Cited by 139
Strategies To Design Selective Histone Deacetylase Inhibitors
Melesina, J., Simoben, C. V., Praetorius, L., Bülbül, E. F., Robaa, D., & Sippl, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202000934 · Cited by 118
Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition
Kidd, S. K., & Schneider, J. S. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.041 · Cited by 113
Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells
Schauber, J., Iffland, K., Frisch, S., Kudlich, T., Schmausser, B., Eck, M., Menzel, T., Gostner, A., Lührs, H., & Scheppach, W. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.05.005 · Cited by 109
Kim, S. W., Hooker, J. M., Otto, N., Win, K., Muench, L., Shea, C., Carter, P., King, P., Reid, A. E., Volkow, N. D., et al. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.06.007 · Cited by 104
Böhm, S. K., Gum, J. R., Erickson, R. H., Hicks, J. W., & Kim, Y. S. (1995) · Biochemical Journal · doi:10.1042/bj3110835 · Cited by 89
Fan, S., Lin, C., Wei, Y., Yeh, S., Tsai, Y., Lee, A. C., Lin, W., & Wang, P. (2021) · Aging Cell · doi:10.1111/acel.13510 · Cited by 63
Histone modifications as a pathogenic mechanism of colorectal tumorigenesis
Gargalionis, A. N., Piperi, C., Adamopoulos, C., & Papavassiliou, A. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.002 · Cited by 53
Metadata
- Authors
- RIGGS, M. G., WHITTAKER, R. G., NEUMANN, J. R., & INGRAM, V. M.
- Venue
- Nature
- Published
- 1977-08
- Volume
- 268
- Issue
- 5619
- Pages
- 462-464
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1998006710
- Cited by
- 787
- References
- 15
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.